Dupilumab Improved Long-term Lung Function in Children Aged 6 to 11 Years With Moderate-to-Severe Asthma: Liberty Asthma Excursion

被引:0
|
作者
Bacharier, L. B. [1 ]
Maspero, J. F. [2 ]
Katelaris, C. H. [3 ]
Fiocchi, A. G. [4 ]
Gagnon, R. [5 ]
de Mir, I. [6 ]
Guilbert, T. W. [7 ,8 ]
Jackson, D. J. [9 ]
Li, N. [10 ]
Akinlade, B. [11 ]
Laws, E. [10 ]
Mannent, L. P. [12 ]
Maloney, J. [11 ]
Tawo, K. [10 ]
Khokhar, F. A. [11 ]
Hardin, M. [13 ]
Abdulai, R. M. [13 ]
Lederer, D. J. [11 ]
Robinson, L. B. [13 ]
机构
[1] Vanderbilt Univ, Med Ctr, Pediat, Nashville, TN USA
[2] Fdn CIDEA, Buenos Aires, DF, Argentina
[3] Campbelltown Hosp, Campbelltown, NSW, Australia
[4] Bambino Gesu Pediat Hosp, IRCCS, Rome, Italy
[5] Clin Specialisee Allergie Capitale, Quebec City, PQ, Canada
[6] Hosp Univ Maternoinfantil Vall dHebron, Barcelona, Spain
[7] Cincinnati Childrens Hosp, Cincinnati, OH USA
[8] Univ Cincinnati, Cincinnati, OH USA
[9] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA
[10] Sanofi, Bridgewater, NJ USA
[11] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[12] Sanofi, Chilly Mazarin, France
[13] Sanofi, Cambridge, MA USA
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
A5988
引用
收藏
页数:2
相关论文
共 50 条
  • [31] DUPILUMAB IMPROVES QUALITY OF LIFE IN CAREGIVERS OF CHILDREN WITH UNCONTROLLED MODERATE-TO-SEVERE ASTHMA: LIBERTY ASTHMA VOYAGE STUDY
    Fiocchi, A. G.
    Phipatanakul, W.
    Durrani, S.
    Cole, J.
    Msihid, J.
    Lederer, D. J.
    Hardin, M.
    Zhang, Y.
    Khan, A. H.
    VALUE IN HEALTH, 2022, 25 (07) : S294 - S295
  • [32] Impact of Exacerbation History on Dupilumab Efficacy in Children with Uncontrolled Moderate-to-Severe Asthma: LIBERTY ASTHMA VOYAGE Study
    Guilbert, Theresa W.
    Tolcachier, Alberto
    Fiocchi, Alessandro G.
    Katelaris, Constance H.
    Phipatanakul, Wanda
    Begin, Philippe
    de Mir, Ines
    Altincatal, Arman
    Gall, Rebecca
    Ledanois, Olivier
    Radwan, Amr
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 143 - 159
  • [33] Dupilumab Improves Quality of Life in Caregivers of Children with Uncontrolled Moderate-to-severe Asthma: LIBERTY ASTHMA VOYAGE Study
    Fiocchi, Alessandro G.
    Phipatanakul, Wanda
    Durrani, Sandy R.
    Cole, Jeremy
    Liu, Dongfang
    Msihid, Jerome
    Lederer, David J.
    Hardin, Megan
    Zhang, Yi
    Khan, Asif H.
    PEDIATRICS, 2022, 149 (01)
  • [34] Dupilumab Improves Lung Function in Children With Moderate-to-Severe Type 2 Asthma at Week 12
    Guilbert, T. W.
    Deschildre, A.
    Murphy, K. R.
    Hamelmann, E.
    Ross, K. R.
    Gupta, A.
    Xia, C.
    Gall, R.
    Ledanois, O.
    Radwan, A.
    Jacob-Nara, J. A.
    Rowe, P. J.
    Deniz, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [35] Dupilumab 200 mg was efficacious in children (6-11 years) with moderate-to-severe asthma for up to 2 years: EXCURSION open-label extension study
    Phipatanakul, Wanda
    Vogelberg, Christian
    Bacharier, Leonard B.
    Dell, Sharon
    Altincatal, Arman
    Gall, Rebecca
    Ledanois, Oliver
    Sacks, Harry
    Jacob-Nara, Juby A.
    Deniz, Yamo
    Rowe, Paul J.
    PEDIATRIC PULMONOLOGY, 2024, 59 (11) : 2976 - 2983
  • [36] Assessment of long-term safety and efficacy of dupilumab in children with asthma (LIBERTY ASTHMA EXCURSION) : an open-label extension study
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Katelaris, Constance H.
    Fiocchi, Alessandro G.
    Gagnon, Remi
    de Mir, Ines
    Guilbert, Theresa W.
    Jackson, Daniel J.
    Staudinger, Heribert W.
    Laws, Elizabeth
    Mannent, Leda P.
    Akinlade, Bolanle
    Maloney, Jennifer
    Tawo, Kelsey
    Khokhar, Faisal A.
    Li, Ning
    Hardin, Megan
    Abdulai, Raolat M.
    Lederer, David J.
    Robinson, Lacey B.
    LANCET RESPIRATORY MEDICINE, 2024, 12 (01): : 45 - 54
  • [37] DUPILUMAB REDUCES SEVERE EXACERBATION RATE AND IMPROVES LUNG FUNCTION IN ADOLESCENT PATIENTS WITH UNCONTROLLED, MODERATE-TO-SEVERE ASTHMA: FROM THE LIBERTY ASTHMA QUEST STUDY
    Maspero, Jorge
    Fitzgerald, Mark
    Pavord, Ian
    Wenzel, Sally
    Zhang, Bingzhi
    Maroni, Jaman
    Rowe, Paul
    Amin, Nikhil
    Pirozzi, Gianluca
    Ruddy, Marcella
    Akinlade, Bolanle
    Graham, Neil
    Teper, Ariel
    CHEST, 2018, 154 (04) : 25A - 27A
  • [38] Dupilumab Reduced Severe Exacerbations and Improved Lung Function in Patients with Uncontrolled, Moderate-to-Severe Asthma with an Eosinophilic Phenotype Across Baseline IgE Levels: LIBERTY ASTHMA QUEST Study
    Carr, W. W.
    Corren, J.
    Casale, T. B.
    Daizadeh, N.
    Khan, A. H.
    Kamat, S.
    Deniz, Y.
    Rowe, P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [39] LONG-TERM EFFECT OF DUPILUMAB ON LUNG FUNCTION IN PATIENTS WITH TYPE 2 ASTHMA: LIBERTY ASTHMA TRAVERSE STUDY
    Papi, Alberto
    Castro, Mario
    Corren, Jonathan
    Pavord, Ian
    Tohda, Yuji
    Daizadeh, Nadia
    Ortiz, Benjamin
    Djandji, Michel
    Ruddy, Marcella
    Laws, Elizabeth
    Mannent, Leda
    Amin, Nikhil
    Gall, Rebecca
    Jacob-Nara, Juby
    Deniz, Yamo
    Rowe, Paul
    Lederer, David
    Hardin, Megan
    CHEST, 2021, 160 (04) : 1854A - 1858A
  • [40] Improved lung function and asthma control observed with rademikibart in patients with moderate-to-severe asthma
    Kerwin, Edward
    Guo, Jiawang
    Adivikolanu, Radha
    Longphre, Malinda
    Wang, Junying
    Yun, Jili
    Pan, Wuban
    Wei, Zheng
    Collazo, Raul
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64